BioPlus Acquisition Corp.

NASDAQ: BIOS · Real-Time Price · USD
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 9:46 PM

BioPlus Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
5.79M 4.58M 2M 422.08K -237.05K -261.97K -152.94 -7.02 -6.14 -5
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items
-7.96M -5.72M -3.17M -1.28M -326.41K -46.06K -691.35 -3.21 6.03 5.00
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
550.21K 298.7K 479.73K 392.01K 289.26K 140.7K n/a n/a n/a n/a
Operating Cash Flow
-1.61M -840.58K -691.47K -461.8K -274.19K -167.34K -844.29 -10.23 -0.11 n/a
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
104.46K n/a n/a -255.93K -255.93K -255.93K -255.93K n/a n/a n/a
Investing Cash Flow
104.46K n/a n/a -255.93K -255.93K -255.93K -255.93K n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-104.71K -67.5 -67.5 -67.5 -67.5 n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
378.12K 440.56K 203.55K 197.28K 189.94K 231.11K 257.46K 11.17 23.80 25.00
Financial Cash Flow
-103.13M 440.56K 203.55K 197.28K 189.94K 231.11K 257.46K 11.17 23.80 25.00
Net Cash Flow
-292.24K -407.35K -495.24K -527.78K -340.18K -192.15K 692.87 0.94 23.69 25.00
Free Cash Flow
-1.61M -840.58K -691.47K -461.8K -274.19K -167.34K -844.29 -10.23 -0.11 n/a